SC 13G | 2017-08-22 | Point72 Asset Management, L.P. | Pacira Pharmaceuticals, Inc. | 2,036,500 | 5.0% | EDGAR |
SC 13G | 2017-08-14 | HealthCor Management, L.P. | Pacira Pharmaceuticals, Inc. | - | 6.2% | EDGAR |
SC 13G | 2017-04-17 | Partner Fund Management, L.P. | Pacira Pharmaceuticals, Inc. | - | 5.7% | EDGAR |
SC 13G/A | 2017-02-14 | GILDER GAGNON HOWE & CO LLC | Pacira Pharmaceuticals, Inc. | 1,231,278 | 3.3% | EDGAR |
SC 13G/A | 2017-02-14 | Visium Asset Management, LP | Pacira Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2017-02-10 | VANGUARD GROUP INC | Pacira Pharmaceuticals, Inc. | 2,747,239 | 7.3% | EDGAR |
SC 13G/A | 2017-02-07 | PRICE T ROWE ASSOCIATES INC /MD/ | Pacira Pharmaceuticals, Inc. | 2,579,501 | 6.8% | EDGAR |
SC 13G/A | 2017-01-25 | BlackRock Inc. | Pacira Pharmaceuticals, Inc. | 3,216,888 | 8.6% | EDGAR |
SC 13G/A | 2017-01-10 | FMR LLC | Pacira Pharmaceuticals, Inc. | 1,754,619 | 4.7% | EDGAR |
SC 13G/A | 2016-02-12 | FMR LLC | Pacira Pharmaceuticals, Inc. | 3,925,537 | 10.7% | EDGAR |
SC 13G/A | 2016-02-12 | GILDER GAGNON HOWE & CO LLC | Pacira Pharmaceuticals, Inc. | 2,220,589 | 6.0% | EDGAR |
SC 13G/A | 2016-02-12 | Visium Asset Management, LP | Pacira Pharmaceuticals, Inc. | 2,001,385 | 5.4% | EDGAR |
SC 13G/A | 2016-02-11 | VANGUARD GROUP INC | Pacira Pharmaceuticals, Inc. | 2,468,838 | 6.7% | EDGAR |
SC 13G/A | 2016-02-10 | PRICE T ROWE ASSOCIATES INC /MD/ | Pacira Pharmaceuticals, Inc. | 4,043,295 | 11.0% | EDGAR |
SC 13G/A | 2016-02-08 | PRUDENTIAL FINANCIAL INC | Pacira Pharmaceuticals, Inc. | 993,050 | 2.7% | EDGAR |
SC 13G/A | 2016-02-03 | JENNISON ASSOCIATES LLC | Pacira Pharmaceuticals, Inc. | 941,987 | 2.6% | EDGAR |
SC 13G/A | 2016-01-27 | BlackRock Inc. | Pacira Pharmaceuticals, Inc. | 2,776,196 | 7.6% | EDGAR |
SC 13G/A | 2015-08-10 | FMR LLC | Pacira Pharmaceuticals, Inc. | 3,840,969 | 10.5% | EDGAR |
SC 13G | 2015-08-10 | Visium Asset Management, LP | Pacira Pharmaceuticals, Inc. | 1,875,700 | 5.1% | EDGAR |
SC 13G/A | 2015-02-13 | PRICE T ROWE ASSOCIATES INC /MD/ | Pacira Pharmaceuticals, Inc. | 4,377,651 | 12.1% | EDGAR |